US Stock MarketDetailed Quotes

MLYS Mineralys Therapeutics

Watchlist

13.060
+0.130+1.01%

Close May 14 16:00 ET

13.060
0.0000.00%

Post 16:02 ET

648.41MMarket Cap-7140P/E (TTM)

Mineralys Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(FY)Dec 31, 2021

Assets

Current assets

Cash, cash equivalents and short term investments

25.10%338.57M

114.85%236.57M

109.80%253.76M

--261.1M

--270.64M

937.60%110.11M

--110.11M

--120.95M

653.16%10.61M

-Cash and cash equivalents

-34.60%90.42M

-43.78%49.3M

76.28%86.3M

--101.14M

--138.25M

726.43%87.7M

--87.7M

--48.96M

653.16%10.61M

-Short-term investments

87.43%248.15M

735.66%187.26M

132.59%167.46M

--159.96M

--132.39M

--22.41M

--72M

--0

Other current assets

78.08%8.25M

364.12%12.54M

1,144.80%11.61M

--8.39M

--4.64M

429.61%2.7M

--2.7M

--933K

794.74%510K

Total current assets

25.99%346.82M

120.81%249.1M

117.72%265.38M

--269.49M

--275.27M

914.30%112.81M

--112.81M

--121.89M

658.66%11.12M

Non current assets

Net PPE

--51K

----

Investments and advances

--0

--2.48M

--12.13M

--21.68M

--31.12M

--0

----

Non current deferred assets

----

-96.87%51K

--0

54,266.67%1.63M

--1.63M

--564K

-85.00%3K

Other non current assets

871.79%379K

----

--51K

--39K

----

Total non current assets

-98.62%430K

55.30%2.53M

2,059.57%12.18M

--21.73M

--31.16M

54,266.67%1.63M

--1.63M

--564K

-85.00%3K

Total assets

13.32%347.25M

119.88%251.64M

126.67%277.56M

--291.22M

--306.44M

928.69%114.44M

--114.44M

--122.45M

648.65%11.13M

Liabilities

Current liabilities

Payables

78.51%4.26M

-68.48%601K

117.44%5.57M

--2.2M

--2.39M

149.93%1.91M

--1.91M

--2.56M

44.23%763K

-accounts payable

78.51%4.26M

-68.48%601K

117.44%5.57M

--2.2M

--2.39M

149.93%1.91M

--1.91M

--2.56M

44.23%763K

Current accrued expenses

83.28%14.28M

50.72%8.28M

87.35%7.97M

--3.25M

--7.79M

38.13%5.5M

--5.5M

--4.25M

7,266.67%3.98M

Current liabilities

81.86%19.2M

29.94%10.48M

87.58%13.54M

--6.21M

--10.56M

59.62%8.07M

--8.07M

--7.22M

-0.57%5.05M

Non current liabilities

Preferred securities outside stock equity

----

--0

447.12%158.64M

--158.64M

--29M

Total non current liabilities

--0

447.12%158.64M

--158.64M

--29M

Total liabilities

81.86%19.2M

-93.71%10.48M

-91.83%13.54M

--6.21M

--10.56M

389.61%166.71M

--166.71M

--165.86M

569.88%34.05M

Shareholders'equity

Share capital

25.00%5K

300.00%4K

--4K

0.00%1K

--1K

0.00%1K

-common stock

25.00%5K

300.00%4K

--4K

0.00%1K

--1K

0.00%1K

Retained earnings

-138.80%-156.22M

-136.14%-124.71M

-129.37%-100.32M

---77.56M

---65.42M

-129.50%-52.81M

---52.81M

---43.74M

-538.66%-23.01M

Paid-in capital

34.04%484.26M

67,651.48%365.86M

113,045.03%364.33M

--362.57M

--361.29M

535.29%540K

--540K

--322K

1,600.00%85K

Total stockholders'equity

10.87%328.05M

561.37%241.15M

708.13%264.01M

--285.01M

--295.88M

-128.00%-52.27M

---52.27M

---43.41M

-537.34%-22.93M

Total equity

10.87%328.05M

561.37%241.15M

708.13%264.01M

--285.01M

--295.88M

-128.00%-52.27M

---52.27M

---43.41M

-537.34%-22.93M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments	25.10%338.57M	114.85%236.57M	114.85%236.57M	109.80%253.76M	--261.1M	--270.64M	937.60%110.11M	--110.11M	--120.95M	653.16%10.61M
-Cash and cash equivalents	-34.60%90.42M	-43.78%49.3M	-43.78%49.3M	76.28%86.3M	--101.14M	--138.25M	726.43%87.7M	--87.7M	--48.96M	653.16%10.61M
-Short-term investments	87.43%248.15M	735.66%187.26M	735.66%187.26M	132.59%167.46M	--159.96M	--132.39M	--22.41M	--22.41M	--72M	--0
Other current assets	78.08%8.25M	364.12%12.54M	364.12%12.54M	1,144.80%11.61M	--8.39M	--4.64M	429.61%2.7M	--2.7M	--933K	794.74%510K
Total current assets	25.99%346.82M	120.81%249.1M	120.81%249.1M	117.72%265.38M	--269.49M	--275.27M	914.30%112.81M	--112.81M	--121.89M	658.66%11.12M
Non current assets
Net PPE	--51K	----	----	----	----	----	----	----	----	----
Investments and advances	--0	--2.48M	--2.48M	--12.13M	--21.68M	--31.12M	--0	--0	----	----
Non current deferred assets	----	-96.87%51K	-96.87%51K	--0	--0	--0	54,266.67%1.63M	--1.63M	--564K	-85.00%3K
Other non current assets	871.79%379K	----	----	--51K	--51K	--39K	----	----	----	----
Total non current assets	-98.62%430K	55.30%2.53M	55.30%2.53M	2,059.57%12.18M	--21.73M	--31.16M	54,266.67%1.63M	--1.63M	--564K	-85.00%3K
Total assets	13.32%347.25M	119.88%251.64M	119.88%251.64M	126.67%277.56M	--291.22M	--306.44M	928.69%114.44M	--114.44M	--122.45M	648.65%11.13M
Liabilities
Current liabilities
Payables	78.51%4.26M	-68.48%601K	-68.48%601K	117.44%5.57M	--2.2M	--2.39M	149.93%1.91M	--1.91M	--2.56M	44.23%763K
-accounts payable	78.51%4.26M	-68.48%601K	-68.48%601K	117.44%5.57M	--2.2M	--2.39M	149.93%1.91M	--1.91M	--2.56M	44.23%763K
Current accrued expenses	83.28%14.28M	50.72%8.28M	50.72%8.28M	87.35%7.97M	--3.25M	--7.79M	38.13%5.5M	--5.5M	--4.25M	7,266.67%3.98M
Current liabilities	81.86%19.2M	29.94%10.48M	29.94%10.48M	87.58%13.54M	--6.21M	--10.56M	59.62%8.07M	--8.07M	--7.22M	-0.57%5.05M
Non current liabilities
Preferred securities outside stock equity	----	--0	--0	--0	--0	--0	447.12%158.64M	--158.64M	--158.64M	--29M
Total non current liabilities	--0	--0	--0	--0	--0	--0	447.12%158.64M	--158.64M	--158.64M	--29M
Total liabilities	81.86%19.2M	-93.71%10.48M	-93.71%10.48M	-91.83%13.54M	--6.21M	--10.56M	389.61%166.71M	--166.71M	--165.86M	569.88%34.05M
Shareholders'equity
Share capital	25.00%5K	300.00%4K	300.00%4K	300.00%4K	--4K	--4K	0.00%1K	--1K	--1K	0.00%1K
-common stock	25.00%5K	300.00%4K	300.00%4K	300.00%4K	--4K	--4K	0.00%1K	--1K	--1K	0.00%1K
Retained earnings	-138.80%-156.22M	-136.14%-124.71M	-136.14%-124.71M	-129.37%-100.32M	---77.56M	---65.42M	-129.50%-52.81M	---52.81M	---43.74M	-538.66%-23.01M
Paid-in capital	34.04%484.26M	67,651.48%365.86M	67,651.48%365.86M	113,045.03%364.33M	--362.57M	--361.29M	535.29%540K	--540K	--322K	1,600.00%85K
Total stockholders'equity	10.87%328.05M	561.37%241.15M	561.37%241.15M	708.13%264.01M	--285.01M	--295.88M	-128.00%-52.27M	---52.27M	---43.41M	-537.34%-22.93M
Total equity	10.87%328.05M	561.37%241.15M	561.37%241.15M	708.13%264.01M	--285.01M	--295.88M	-128.00%-52.27M	---52.27M	---43.41M	-537.34%-22.93M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall